Bayer Aktiengesellschaft (OTCMKTS:BAYRY), founded in 1863 and headquartered in Leverkusen, Germany, is a global life sciences company with core competencies in healthcare and agriculture. Over its 160-year history, Bayer has evolved from a regional chemical producer into one of the world’s leading innovators in pharmaceuticals, consumer health products and crop science. The company’s mission emphasizes advancing health and nutrition for people and animals, underpinned by ongoing investment in research and development.
In the pharmaceutical segment, Bayer develops and markets prescription medicines in areas such as cardiology, women’s health, hematology, oncology and ophthalmology. Its consumer health division offers well-known over-the-counter remedies for everyday ailments, ranging from pain management to allergy relief, supported by strong global brands. Following the 2018 acquisition of Monsanto, Bayer’s crop science business spans seeds and traits, crop protection solutions and digital farming tools, providing integrated offerings to farmers in major agricultural markets worldwide.
Bayer maintains a broad international footprint, serving customers across Europe, the Americas, Asia-Pacific and emerging markets. The company operates research facilities in Germany, the United States and other key innovation hubs, collaborating with academic institutions and industry partners to advance new therapies and sustainable agricultural practices. Bayer’s leadership team is headed by CEO Bill Anderson, whose tenure focuses on driving operational excellence, enhancing the product pipeline and strengthening the company’s sustainability commitments.
